RFK Jr. Walks a Tightrope on Trump Deal for Obesity Drugsnews2025-11-14T10:02:07+00:00November 14th, 2025|The New York Times|
Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Dealnews2025-11-08T12:38:25+00:00November 8th, 2025|The New York Times|
What Trump’s New Drug Pricing Deal Means for People With Obesitynews2025-11-06T21:53:59+00:00November 6th, 2025|The New York Times|
Costco to Sell Ozempic and Wegovy, Weight-Loss Wonder Drugsnews2025-10-05T19:47:27+00:00October 5th, 2025|The New York Times|
How Private Equity Oversees the Ethics of Drug Researchnews2025-10-04T09:00:13+00:00October 4th, 2025|The New York Times|
Novo Nordisk’s Woes Are Slimming Denmark’s Economic Growthnews2025-09-22T04:01:17+00:00September 22nd, 2025|The New York Times|
Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertisernews2025-09-12T22:09:11+00:00September 12th, 2025|The New York Times|
Ozempic Maker Novo Nordisk to Cut 9,000 Jobsnews2025-09-10T15:46:41+00:00September 10th, 2025|The New York Times|
Where U.S. Medicines Are Made and How Trump’s Tariffs Could Affect Themnews2025-08-24T03:39:58+00:00August 24th, 2025|The New York Times|
Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warningnews2025-07-29T17:51:03+00:00July 29th, 2025|The New York Times|
